← Leaderboards
Piotr J Kraj
Medical College Of Georgia (Mcg)
$3,592,099
Attributed
$3,592,099
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $535.8K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,592,099 · 5
By mechanism
R01$2,576,330 · 2
R21$860,769 · 2
R03$155,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical College Of Georgia (Mcg)
Same institution · by research overlap
- Nancy R Manley$17,506,795
Others in their field
Top investigators on “Cd4 Positive T Lymphocytes”
- Barton F Haynes · Duke University$185,201,094
- James Dennis Neaton · Northwestern University$75,155,718
- Sharon A Nachman · Johns Hopkins University$74,725,055
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$62,274,832
- Dennis R. Burton · Scripps Research Institute$60,411,078
- Rama Rao Amara · Emory University$55,598,235
Research focus
Cd4 Positive T LymphocytesCytokineCellsPhenotypeResponseT-Lymphocyte SubsetsPeripheralImmune ResponseT-LymphocyteAntigensRegulatory T-LymphocyteLesionReceptorEffector CellImmuneTumorMalignant NeoplasmsGenerationsTissuesCell PhysiologyInflammatoryClonal ExpansionImmune SystemAntigen-Presenting Cells
Grant awards (17)
Bone Morphogenic Protein Receptor 1a signaling controls stability of Treg cell phenotype$200,569
R21 · FY2024 · AI · contact PI
Bone Morphogenic Protein Receptor 1a signaling controls stability of Treg cell phenotype$247,989
R21 · FY2023 · AI · contact PI
Bone Morphogenic Protein signaling in Th/Treg lineage specification$77,500
R03 · FY2022 · AI · contact PI
Bone Morphogenic Protein signaling in Th/Treg lineage specification$77,500
R03 · FY2021 · AI · contact PI
Modulation of regulatory cell function in cancer immunotherapy$317,475
R01 · FY2015 · CA · contact PI
Modulation of regulatory cell function in cancer immunotherapy$307,951
R01 · FY2014 · CA · contact PI
Modulation of regulatory cell function in cancer immunotherapy$292,575
R01 · FY2013 · CA · contact PI
Modulation of Bone Morphogenic Protein signaling for cancer immunotherapy$176,853
R21 · FY2013 · AI · contact PI
Modulation of Bone Morphogenic Protein signaling for cancer immunotherapy$10,858
R21 · FY2013 · AI · contact PI
Modulation of regulatory cell function in cancer immunotherapy$311,250
R01 · FY2012 · CA · contact PI
Modulation of Bone Morphogenic Protein signaling for cancer immunotherapy$224,500
R21 · FY2012 · AI · contact PI
Modulation of regulatory cell function in cancer immunotherapy$309,521
R01 · FY2011 · CA · contact PI
CD4+ T cell subset function in antitumor immune response$204,062
R01 · FY2009 · CA · contact PI
CD4+ T cell subset function in antitumor immune response$204,062
R01 · FY2008 · CA · contact PI
CD4+ T cell subset function in antitumor immune response$204,062
R01 · FY2007 · CA · contact PI
CD4+ T cell subset function in antitumor immune response$210,157
R01 · FY2006 · CA · contact PI
CD4+ T cell subset function in antitumor immune response$215,215
R01 · FY2005 · CA